News & Updates

Expanding SGLT2 inhibitor use in CKD: Why and how?

19 Dec 2023 by

Early detection of chronic kidney disease (CKD) enables early optimization of organ-protective treatment to help avert the substantial healthcare burden associated with the condition. At an industry-sponsored symposium organized by the Asian Pacific Society of Nephrology (APSN), Professor See-Cheng Yeo of Tan Tock Seng Hospital, Singapore, and Professor Meg Jardine of the University of Sydney, Australia, discussed evidence supporting earlier and broader use of sodium-glucose cotransporter 2 (SGLT2) inhibitors (eg, empagliflozin) in CKD, highlighting guideline recommendations for SGLT2 inhibitors as first-line (1L) therapy in diabetic kidney disease (DKD) patients with estimated glomerular filtration rate (eGFR) ≥20 mL/min/1.73 m².

Expanding SGLT2 inhibitor use in CKD: Why and how?

19 Dec 2023

Even seemingly healthy teens with high BMI at risk of early CKD

18 Dec 2023

High body mass index (BMI) in late adolescence appears to be a risk factor for chronic kidney disease (CKD) in young adulthood, even for seemingly healthy individuals with a BMI that falls within the normal range but is closer to the upper limit, as reported in a study.

Even seemingly healthy teens with high BMI at risk of early CKD

18 Dec 2023

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

18 Dec 2023 by

Etelcalcetide proves beneficial in the real-world treatment of secondary hyperparathyroidism (SHPT) in multiethnic Asian haemodialysis patients, with the added advantage of reducing pill burden, as shown in a study from Singapore.

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

18 Dec 2023

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D

17 Dec 2023

Early albuminuria reduction with finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is responsible for a huge proportion of the treatment effect against CKD progression and facilitates a modest amount of the effect against cardiovascular outcomes, reports a study.

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D

17 Dec 2023

$Supplementation does little to reduce fractures in schoolchildren with vitamin D deficiency$

Supplementation does little to reduce fractures in schoolchildren with vitamin D deficiency

16 Dec 2023

Among schoolchildren with a high baseline prevalence of vitamin D deficiency, oral supplementation with vitamin D for 3 years is safe but falls short of reducing the risk of fracture, according to a study.

Supplementation does little to reduce fractures in schoolchildren with vitamin D deficiency

16 Dec 2023

Weight loss with tirzepatide reversed after stopping treatment

16 Dec 2023 by

For individuals with overweight or obesity who are taking tirzepatide for weight management, continued treatment results in sustained and even augmented weight loss. When treatment is stopped, however, the achieved weight loss is substantially reversed.

Weight loss with tirzepatide reversed after stopping treatment

16 Dec 2023

Breakthrough SARS-CoV-2 infection does not affect blood sugar control in T1D patients

16 Dec 2023

Patients with type 1 diabetes (T1D) who have been vaccinated against COVID-19 do not appear to have worsened glycaemic control, according to a study.

Breakthrough SARS-CoV-2 infection does not affect blood sugar control in T1D patients

16 Dec 2023

Teplizumab preserves ß-cell function in children with new-onset T1D

15 Dec 2023 by

Treatment with teplizumab significantly preserved beta(ß)-cell function, as measured by C-peptide levels, in children and adolescents with new-onset type 1 diabetes (T1D) compared with placebo, according to the PROTECT* study.

Teplizumab preserves ß-cell function in children with new-onset T1D

15 Dec 2023

Vegan better than omnivorous diet for heart and metabolism

12 Dec 2023 by

Vegan diet confers cardiometabolic advantages compared with healthy omnivorous diet, as shown in a twins study.

Vegan better than omnivorous diet for heart and metabolism

12 Dec 2023

Obesity persists in axSpA, especially in socially deprived patients

11 Dec 2023

Obesity appears to be prevalent among patients with axial spondyloarthritis (axSpA) compared to the general population, according to a Swiss study, noting that socially disadvantaged individuals are most affected by this comorbidity.

Obesity persists in axSpA, especially in socially deprived patients

11 Dec 2023

News & Updates

Filter by Specialty:

Specialty:

Expanding SGLT2 inhibitor use in CKD: Why and how?

Expanding SGLT2 inhibitor use in CKD: Why and how?

Even seemingly healthy teens with high BMI at risk of early CKD

Even seemingly healthy teens with high BMI at risk of early CKD

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D

Supplementation does little to reduce fractures in schoolchildren with vitamin D deficiency

Supplementation does little to reduce fractures in schoolchildren with vitamin D deficiency

Weight loss with tirzepatide reversed after stopping treatment

Weight loss with tirzepatide reversed after stopping treatment

Breakthrough SARS-CoV-2 infection does not affect blood sugar control in T1D patients

Breakthrough SARS-CoV-2 infection does not affect blood sugar control in T1D patients

Teplizumab preserves ß-cell function in children with new-onset T1D

Teplizumab preserves ß-cell function in children with new-onset T1D

Vegan better than omnivorous diet for heart and metabolism

Vegan better than omnivorous diet for heart and metabolism

Obesity persists in axSpA, especially in socially deprived patients

Obesity persists in axSpA, especially in socially deprived patients